The Drug Administration of Vietnam (DAV), under the Ministry of Health, issued Decision No. 629/QD-QLD, extending the registration certificates for five vaccines and biological products to allow for their continued circulation in Vietnam. The extensions are effective immediately and valid for up to five years.

Key highlights:

  • Ensures uninterrupted availability of approved vaccines and biologicals.
  • Lists licensed companies, active ingredients, specifications, and registration numbers.
  • Requires manufacturers and registrants to maintain product quality and Regulatory compliance.
  • Products include:
    • Inactivated V. cholerae vaccines – Vaccine and Biological No. 1 Co., Ltd.
    • Lupiparin – Lupin Limited / Shenzhen Techdow Pharmaceutical Co., Ltd.
    • Clostridium botulinum toxin type A – Daewoong Pharmaceutical Co., Ltd.
    • Enoxaparin sodium – Emcure Pharmaceuticals Limited.

This decision strengthens Vietnam’s vaccine lifecycle management and post-market oversight framework.

Consult Now

Source
https://dav.gov.vn/upload_images/files/629_QD_QLD%202025_signed.pdf
Select Mandate HA
DAV
Select Mandate Function
Regulatory Affairs